Mahavir Advanced Remedies Ltd.

Name: Mahavir Advanced Remedies Ltd. Share Price Today, Stock Analysis
Brand: Mahavir Advanced Remedies Ltd.

Stock Card

BSE: 531689

₹150.65

₹-3.05 (-1.98%)

As on 06-Jan-2015IST

Market cap

₹171 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

660.7

P/B Ratio

19.2

Div. Yield

0 %

Mahavir Advanced Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 150.65 High: 150.65

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

₹0 Cr
ROE

1.6 %
ROCE

1.6 %
Industry P/E

44.97
EV/EBITDA

782.7
Debt to Equity

0
Book Value

₹--
EPS

₹0.2
Face value

10
Shares outstanding

11,359,200

5 Years Aggregate

CFO

₹-7.69 Cr

EBITDA

₹-0.58 Cr

Net Profit

₹-0.44 Cr

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Mahavir Advanced	-8.4	-52.3	-56.6	147.5	--	--	--
BSE Sensex^*	-9.6	-2.7	2.9	-5.0	5.4	5.7	10.4
BSE Healthcare^#	17.2	0.3	9.5	15.1	22.5	13.7	12.1

As on 06-Jan-2015 | *As on 04-Sep-2026 | #As on 04-Sep-2026

Company	2014
Mahavir Advanced	167.4
BSE Sensex	29.9
BSE Healthcare	47.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price (₹)	Market Cap (₹ Cr)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Mahavir Advanced	150.7	171.1	0.2	0.3	0.5	2.9	660.7	19.2
Acutaas Chemicals	3,168.5	25,922.9	1,461.8	387.4	34.5	25.2	67.1	15.0
Alembic Pharma	808.2	15,878.4	7,784.0	688.5	10.6	14	22.9	2.7
Cohance Lifesciences	456.6	17,467.5	2,141.5	58.5	5.8	3.3	164.4	4.5
Granules India	848.3	21,003.3	5,632.3	662.4	17.2	14.3	31.7	4.3
Onesource Specialty Pharma	1,537.8	17,587.4	1,543.3	-48.6	3.6	-0.6	--	3.0
Piramal Pharma	214.2	28,517.5	9,205.3	-371.8	1.7	-3.8	--	3.6
Rubicon Research	1,768.3	29,353.0	1,935.8	288.2	20.6	29.8	101.8	21.9
Syngene Intl	395.6	15,971.2	3,600.2	221.0	9.7	5.6	72.3	3.4
Wockhardt	2,088.7	33,908.1	3,564.0	414.0	15.3	8.4	82.9	6.7

Shareholding Pattern

View Details

News & Analysis

All News

No Review & Analysis are available.

About Mahavir Advanced

Manufacture of allopathic pharmaceutical preparations

Incorporated

1992
Chairman

BVS Koteswara Rao
Managing Director

BVS Koteswara Rao
Headquarters

Chennai, Tamil Nadu
Website

--

FAQs for Mahavir Advanced

What is the current share price of Mahavir Advanced Remedies Ltd Today?

The share price of Mahavir Advanced Remedies Ltd is ₹150.65 (BSE) as of 06-Jan-2015 IST. Mahavir Advanced Remedies Ltd has given a return of 147.5% in the last 1 years.

What is the current PB & PE ratio of Mahavir Advanced Remedies Ltd?

The P/E ratio of Mahavir Advanced Remedies Ltd is 660.72 times as on 06-Jan-2015, a 1369 premium to its peers’ median range of 44.97 times.
The P/B ratio of Mahavir Advanced Remedies Ltd is 19.18 times as on 06-Jan-2015, a 322 premium to its peers’ median range of 4.54 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2014	1,613.77	25.28
2013	0.00	0.00
2012	0.00	0.00
2011	0.00	0.00
2010	0.00	0.00

What is the 52 Week High and Low of Mahavir Advanced Remedies Ltd?

The 52-week high and low of Mahavir Advanced Remedies Ltd are Rs -- and Rs -- as of 07-Sep-2026.

What is the market cap of Mahavir Advanced Remedies Ltd?

Mahavir Advanced Remedies Ltd has a market capitalisation of ₹ 171 Cr as on 06-Jan-2015. As per SEBI classification, it is a company.

Should I invest in Mahavir Advanced Remedies Ltd?

Before investing in Mahavir Advanced Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.